VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,831 | -53.0% | 542,899 | -46.5% | 0.00% | -75.0% |
| Q1 2024 | $10,280 | +129.7% | 1,014,679 | +128.2% | 0.00% | +100.0% |
| Q4 2023 | $4,475 | +15.8% | 444,694 | +7.9% | 0.00% | 0.0% |
| Q3 2023 | $3,863 | -14.2% | 412,161 | +124.6% | 0.00% | -33.3% |
| Q2 2023 | $4,502 | -16.8% | 183,527 | -21.1% | 0.00% | +50.0% |
| Q1 2023 | $5,411 | +9.0% | 232,502 | +18.5% | 0.00% | 0.0% |
| Q4 2022 | $4,966 | -99.9% | 196,225 | -18.1% | 0.00% | -60.0% |
| Q3 2022 | $4,617,000 | +529.0% | 239,488 | +732.2% | 0.01% | – |
| Q2 2022 | $734,000 | -71.7% | 28,777 | -71.5% | 0.00% | -100.0% |
| Q1 2022 | $2,595,000 | – | 100,891 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $39,700,000 | 30.52% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $565,858,000 | 4.50% |
| Zebra Capital Management LLC | 25,419 | $647,000 | 1.90% |
| Alaska Permanent Fund Corp | 2,300,000 | $58,581,000 | 0.84% |
| CLARK ESTATES INC/NY | 180,000 | $4,585,000 | 0.79% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $142,697,025 | 0.78% |
| SECTOR GAMMA AS | 110,223 | $2,807,000 | 0.63% |
| Avidity Partners Management LP | 758,211 | $19,312,000 | 0.44% |
| New Vernon Capital Holdings II LLC | 14,501 | $369,000 | 0.30% |
| DUALITY ADVISERS, LP | 116,415 | $2,965,000 | 0.29% |